drugset / Trial / NCT05723276

Psilocybin in Functional Neurological Disorder

NCT05723276

Active not recruiting 24 enrolled King's College London
NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to learn about the brain network response in people who have functional neurological disorder who are administered with a single dose of the psychedelic psilocybin with therapeutic support. The main question it aims to answer is: Can the default mode network, a brain network thought to be relevent in FND, be modified by the administration of psilocybin based on functional magnetic resonance imaging before and after the dose?

Timeline

Start
2024-02-14
Primary completion
2026-05
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg Oral

Indications